Key result
Expression of the HCM-associated cMyBP-C C10mut protein in cultured rat cardiomyocytes led to improper sarcomere localization and significantly reduced fractional shortening and relaxation velocities.
The study provides mechanistic evidence that the South Asian-specific MYBPC3 25-base pair deletion causes hypertrophic cardiomyopathy through improper protein localization and contractile dysfunction.
Answers are grounded in this paper and cite their sources.
Offers mechanistic clues for MYBPC3 HCM; leaves open clinical translation pending human validation.
Hypertrophic cardiomyopathy (HCM) results from mutations in genes encoding sarcomeric proteins, most often MYBPC3 , which encodes cardiac myosin binding protein-C (cMyBP-C). A recently discovered HCM-associated 25-base pair deletion in MYBPC3 is inherited in millions worldwide. Although this mutation causes changes in the C10 domain of cMyBP-C (cMyBP-C C10mut ), which binds to the light meromyosin (LMM) region of the myosin heavy chain, the underlying molecular mechanism causing HCM is unknown. In this study, adenoviral expression of cMyBP-C C10mut in cultured adult rat cardiomyocytes was used to investigate protein localization and evaluate contractile function and Ca 2+ transients, compared with wild-type cMyBP-C expression (cMyBP-C WT ) and controls. Forty-eight hours after infection, 44% of cMyBP-C WT and 36% of cMyBP-C C10mut protein levels were determined in total lysates, confirming equal expression. Immunofluorescence experiments showed little or no localization of cMyBP-C C10mut to the C-zone, whereas cMyBP-C WT mostly showed C-zone staining, suggesting that cMyBP-C C10mut could not properly integrate in the C-zone of the sarcomere. Subcellular fractionation confirmed that most cMyBP-C C10mut resided in the soluble fraction, with reduced presence in the myofilament fraction. Also, cMyBP-C C10mut displayed significantly reduced fractional shortening, sarcomere shortening, and relaxation velocities, apparently caused by defects in sarcomere function, because Ca 2+ transients were unaffected. Co-sedimentation and protein cross-linking assays confirmed that C10 mut causes the loss of C10 domain interaction with myosin LMM. Protein homology modeling studies showed significant structural perturbation in cMyBP-C C10mut , providing a potential structural basis for the alteration in its mode of interaction with myosin LMM. Therefore, expression of cMyBP-C C10mut protein is sufficient to cause contractile dysfunction in vitro . Background A 25-base pair deletion in the MYBPC3 gene is the most prevalent hypertrophic cardiomyopathy-associated mutation among South Asian populations. Results Expression of mutant protein (cMyBP-C C10mut ) in cultured adult rat cardiomyocytes led to improper localization and contractile dysfunction. Conclusion cMyBP-C C10mut expression is sufficient to cause contractile dysfunction. Significance The study sheds light on the etiology of this ethnic-specific hypertrophic cardiomyopathy mutation.
No takes yet. Share an insight, caveat, or question.
Kuster et al. (2015) studied Hypertrophic cardiomyopathy. Adenoviral expression of cMyBP-C C10mut vs. Wild-type cMyBP-C expression and controls was evaluated on Protein localization, contractile function, and Ca2+ transients. Expression of the HCM-associated cMyBP-C C10mut protein in cultured rat cardiomyocytes led to improper sarcomere localization and significantly reduced fractional shortening and relaxation velocities.
Synapse has enriched 10 related papers. Consider them for comparative context: